|
Table 1. HIV Associated Atypical Cutaneous Lymphoproliferative Disorder (ACLD) [1 – 10], Reported Treatments |
|||
|
Treatment |
Cases Treated No. |
Cases Treated with Improvement No. (%) |
Cases Treated with Substantial Improvement or Resolution No. (%) |
|
Systemic Corticosteroids |
4 |
3 (75) |
2 (50) |
|
Topical Corticosteroids |
21 |
4 (19) |
1 (5) |
|
PUVA |
10 |
5 (50) |
0 (0) |
|
UVB |
5 |
0 (0) |
0 (0) |
|
Retinoid |
3 |
0 (0) |
0 (0) |
|
Chemotherapy |
2 |
0 (0) |
0 (0) |
|
Antiretroviral therapy |
2 |
2 (100) |
2 (100) |
|
PUVA, Psoralen and Ultraviolet A; UVB, Ultraviolet B |
|||